Autologous vs. Allogeneic Cells
Cross-source consensus on Autologous vs. Allogeneic Cells from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Benefits
Risks & contraindications
Comparisons
Background
Highlighted claims
- Using a patient’s own cells eliminates compatibility concerns because mitochondrial and nuclear DNA match. — Full Body Stem Cell Makeover and VSEL Technology
- The article argues that VSELs address the concern that autologous cells are too old by maintaining youthful cellular characteristics regardless of patient age. — Full Body Stem Cell Makeover and VSEL Technology
- The article says FDA enforcement largely shut down the U.S. umbilical cord stem cell industry. — Full Body Stem Cell Makeover and VSEL Technology
- Even premium international settings are described as having inherently difficult quality control because of supply-chain complexity. — Full Body Stem Cell Makeover and VSEL Technology
- Allogeneic umbilical cord supply chains introduce risks related to donors, pathogen testing, processing, storage, shipping, viability, and contamination. — Full Body Stem Cell Makeover and VSEL Technology
- Umbilical cord stem cells remain commonly used outside the United States. — Full Body Stem Cell Makeover and VSEL Technology